Efficacy of phage therapy to prevent mortality during the vibriosis of brine shrimp

Aquaculture

Volumn 400-401, Issue , 2013, Pages 120-124

  Martinez Diaz S F ^a   Hipolito Morales A ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Artemia franciscana; Phage therapy; Vibrio parahaemolyticus; Vibriosis

Indexed keywords

BACTERIUM; BIOCONTROL AGENT; DISEASE CONTROL; INFECTIOUS DISEASE; MORTALITY; SHRIMP CULTURE;

ARTEMIA; ARTEMIA FRANCISCANA; BACTERIA (MICROORGANISMS); VIBRIO PARAHAEMOLYTICUS;

EID: 84875947496     PISSN: 00448486     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aquaculture.2013.03.007     Document Type: Article

References (33)

1. Almeida A., Cunha A., Gomes N.C.M., Alves E., Costa L., Faustino M.A.F. Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants. Marine Drugs 2009, 7:268-313.
2. Carlson K. Working with bacteriophages: common techniques and methodological approaches. Bacteriophages: Biology and Applications 2005, CRC Press, USA. E. Kutter, A. Sulakvelidze (Eds.).
3. Da Silva, L.V.A., 2005. Control of Vibrio vulnificus and Vibrio parahaemolyticus in oysters. Ph. D. Thesis. Louisiana State University and Agricultural and Mechanical College.
4. Dierckens K., Rekecki A., Laureau S., Sorgeloos P., Boon N., Van den Broeck W., Bossier P. Development of a bacterial challenge test for gnotobiotic sea bass (Dicentrarchus labrax) larvae. Environmental Microbiology 2009, 11(2):526-533.
5. Efrony R., Loya Y., Bacharach E., Rosenberg E. Phage therapy of coral disease. Coral Reefs 2007, 26:7-13.
6. FAO/OIE/WHO Antimicrobial use in aquaculture and antimicrobial resistance. Report of a Joint FAO/OIE/WHO Expert Consultation on Antimicrobial Use in Aquaculture and Antimicrobial Resistance 2006, Department of Food Safety, Zoonoses and Foodborne Diseases, World Health Organization, Geneva, Switzerland, Seoul, Republic of Korea, (www.who.int/foodborne_disease/resistance/en/).
7. García E., López R. Los bacteriofagos y sus productos genicos como agentes antimicrobianos. Revista Española de Quimioterapia 2002, 15(4):306-312.
8. Goodridge L., Abedon S.T. Bacteriophage biocontrol and bioprocessing: application of phage therapy to industry. SIM News 2003, 53:254-262.
9. Imbeault S., Parent S., Lagacé M., Uhland C.F., Blais J.F. Using bacteriophages to prevent furunculosis caused by Aeromonas salmonicida in farmed brook trout. Journal of Aquatic Animal Health 2006, 18:203-214.
10. Karunasagar I., Vinod M., Kennedy B., Vijay A., Deepanjali A., Umesh K., Karunasagar I. Biocontrol of bacterial pathogens in aquaculture with emphasis on phage therapy. Fish Health Section 2005, 535-542. Asian Fisheries Society, Manila. P. Walker, R. Lester, M.G. Bondad-Reantaso (Eds.).
11. Karunasagar I., Shivu M.M., Girisha S.K., Krohne G., Karunasagar I. Biocontrol of pathogens in shrimp hatcheries using bacteriophages. Aquaculture 2007, 268:288-292.
12. Kutter E., Sulakvelidze A. Bacteriophages: Biology and Applications 2005, CRC Press, USA.
13. Levin B.R., Bull J.J. Population and evolutionary dynamics of phage therapy. Nature Reviews Microbiology 2005, 2:166-173.
14. Li T., Xiang J., Liu R., Ding M., Shi P., Wang S. Studies on bacteriophage control pustule disease of abalone Haliotis discus hannai. Oceanologia et Limnologia Sinica 1999, 30:374-380.
15. Marques A., Dinh T., Loakeimidis C., Huys G., Swings J., Verstraete W., Dhont J., Sorgeloos P., Bossier P. Effects of bacteria on Artemia franciscana cultured in different gnotobiotic environments. Applied and Environmental Microbiology 2005, 71(8):4307-4317.
16. Martínez Díaz S.F., Álvarez-González C.A., Moreno-Legorreta M., Vazquez-Juarez R., Barrios-González J. Elimination of the associated microbial community and bioencapsulation of bacteria in the rotifer Brachionus plicatilis. Aquaculture International 2003, 11:95-108.
17. Martin G.G., Rubin N., Swanson E. Vibrio parahaemolyticus and V. harveyi cause detachment of the epithelium from the midgut trunk of the penaeid shrimp Sicyonia ingentis. Diseases of Aquatic Organisms 2004, 60:21-29.
18. Matsuzaki S., Rashel M., Uchiyama J., Sakurai S., Ujihara T., Kuroda M., Ikeuchi M., Tani T., Fujieda M., Wakiguchi H., Imai S. Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. Journal of Infection and Chemotherapy 2005, 11(5):211-219.
19. Morrison S., Rainnie D.J. Bacteriophage therapy: an alternative to antibiotic therapy in aquaculture?. Canadian Technical Report of Fisheries and Aquatic Sciences 2004, 2532:1-23.
20. Nakai T., Park S.C. Bacteriophage therapy of infectious diseases in aquaculture. Research in Microbiology 2002, 153:13-18.
21. Nakai T., Sugimoto R., Park K.H., Matsuoka S., Mori K., Nishioka T., Maruyama K. Protective effects of bacteriophage on experimental Lactococcus garviae infection in yellowail. Diseases of Aquatic Organisms 1999, 37:33-41.
22. Park S.C., Nakai T. Bacteriophage control of Pseudomonas plecoglossicida infection in ayu Plecoglossus altivelis. Diseases of Aquatic Organisms 2003, 53:33-39.
23. Park S.C., Shimamura I., Fukunaga M., Mori K.I., Nakai T. Isolation of bacteriophages specific to a fish pathogen Pseudomonas plecoglossicida as a candidate for disease control. Applied and Environmental Microbiology 2000, 66:1416-1422.
24. Payne R.J.H., Jensen V.A.A. Pharmacokinetic principles of bacteriophage therapy. Clinical Pharmacokinetics 2003, 42(4):315-325.
25. Pelon W., Luftig R.B., Johnston K.H. Vibrio vulnificus load reduction in oysters after combined exposure to V. vulnificus-specific bacteriophage and an oyster extract component. Journal of Food Protection 2005, 68:1188-1191.
26. Projan S. Phage-inspired antibiotics?. Nature Biotechnology 2004, 22(2):167-168.
27. Ronda C., Vázquez M., López R. Los bacteriófagos como herramienta para combatir infecciones en Acuicultura. Revista AquaTIC 2003, 18:3-10.
28. Shivu M.M., Rajeeva B.C., Girisha S.K., Karunasagar I., Krohne G., Karunasagar I. Molecular characterization of Vibrio harveyi bacteriophages isolated from aquaculture environments along the coast of India. Environmental Microbiology 2007, 9(2):322-331.
29. Tai-wu L. Studies on phage control of pustule disease in abalone Haliotis discus hannai. Journal of Shellfish Research 2000, 19:535.
30. Teplitski M., Wright A., Lorca G. Biological approaches for controlling shellfish-associated pathogens. Current Opinion in Biotechnology 2009, 20(2):185-190.
31. Verner-Jeffreys D.W., Algoet M., Pond M.J., Virdee H.K., Bagwell N.J., Roberts E.J. Furunculosis in Atlantic salmon (Salmo salar L.) is not readily controllable by bacteriophage therapy. Aquaculture 2007, 270:475-484.
32. Vinod M.G., Shivu M.M., Umesh K.R., Rajeeva B.C., Karunasagar I., Karunasagar I. Isolation of Vibrio harveyi bacteriophages with a potential for biocontrol of this pathogen in hatchery environments. Aquaculture 2006, 255:117-124.
33. Wiggins B.A., Alexander M. Minimum bacterial density for bacteriophage replication: implications for significance of bacteriophages in natural ecosystems. Applied and Environmental Microbiology 1985, 49:19-23.